Statins and diabetes: focus on pitavastatin
In this review, the focus is to investigate the effects of long-term statin therapy on glucose metabolism. The author analyzed the evidences of randomized clinical trials, meta-analyses, and experimental studies indicating the diabetogenic effect of the most of statins. Possible mechanisms of influe...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Concilium Medicum
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2cf24e86d6744d7c939504863574c218 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2cf24e86d6744d7c939504863574c218 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2cf24e86d6744d7c939504863574c2182021-12-01T22:07:01ZStatins and diabetes: focus on pitavastatin2221-71852658-570710.26442/22217185.2020.2.200226https://doaj.org/article/2cf24e86d6744d7c939504863574c2182020-09-01T00:00:00Zhttps://cardiosomatics.orscience.ru/2221-7185/article/viewFile/46030/31034https://doaj.org/toc/2221-7185https://doaj.org/toc/2658-5707In this review, the focus is to investigate the effects of long-term statin therapy on glucose metabolism. The author analyzed the evidences of randomized clinical trials, meta-analyses, and experimental studies indicating the diabetogenic effect of the most of statins. Possible mechanisms of influence of statins on carbohydrate metabolism are presented. Particular attention is paid to the place of pitavastatin, due to its low diabetogenicity and minimal risk of drug interactions, as well as the need of taking into consideration the risk factors of diabetes and the preventive measures in patients receiving statin therapy.Soreiia A. UrazgildeevaConcilium Medicumarticlediabetes mellituslipid-lowering therapystatinsatorvastatinrosuvastatinpitavastatinDiseases of the circulatory (Cardiovascular) systemRC666-701Diseases of the endocrine glands. Clinical endocrinologyRC648-665ENRUКардиоСоматика, Vol 11, Iss 2, Pp 40-49 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
diabetes mellitus lipid-lowering therapy statins atorvastatin rosuvastatin pitavastatin Diseases of the circulatory (Cardiovascular) system RC666-701 Diseases of the endocrine glands. Clinical endocrinology RC648-665 |
spellingShingle |
diabetes mellitus lipid-lowering therapy statins atorvastatin rosuvastatin pitavastatin Diseases of the circulatory (Cardiovascular) system RC666-701 Diseases of the endocrine glands. Clinical endocrinology RC648-665 Soreiia A. Urazgildeeva Statins and diabetes: focus on pitavastatin |
description |
In this review, the focus is to investigate the effects of long-term statin therapy on glucose metabolism. The author analyzed the evidences of randomized clinical trials, meta-analyses, and experimental studies indicating the diabetogenic effect of the most of statins. Possible mechanisms of influence of statins on carbohydrate metabolism are presented. Particular attention is paid to the place of pitavastatin, due to its low diabetogenicity and minimal risk of drug interactions, as well as the need of taking into consideration the risk factors of diabetes and the preventive measures in patients receiving statin therapy. |
format |
article |
author |
Soreiia A. Urazgildeeva |
author_facet |
Soreiia A. Urazgildeeva |
author_sort |
Soreiia A. Urazgildeeva |
title |
Statins and diabetes: focus on pitavastatin |
title_short |
Statins and diabetes: focus on pitavastatin |
title_full |
Statins and diabetes: focus on pitavastatin |
title_fullStr |
Statins and diabetes: focus on pitavastatin |
title_full_unstemmed |
Statins and diabetes: focus on pitavastatin |
title_sort |
statins and diabetes: focus on pitavastatin |
publisher |
Concilium Medicum |
publishDate |
2020 |
url |
https://doaj.org/article/2cf24e86d6744d7c939504863574c218 |
work_keys_str_mv |
AT soreiiaaurazgildeeva statinsanddiabetesfocusonpitavastatin |
_version_ |
1718404151636918272 |